疫情前肺功能与结构同COVID-19结局的关联:C4R研究
基于美国11个前瞻性人群队列中29,323名参与者(平均年龄67岁),评估疫情前肺功能与CT结构指标与2020-2023年COVID-19结局的关联。中位随访17.3个月期间发生748例重症COVID-19;疫情前重度阻塞、限制性通气障碍及较高肺气肿百分比与重症COVID-19风险升高相关,而高衰减区百分比和间质性肺异常未见关联。
要点
- 疫情前重度阻塞(FEV1<50%)与重症COVID-19风险升高相关(aHR 2.11)。
- 限制性通气障碍与肺气肿百分比最高四分位亦与重症COVID-19风险升高相关。
- 高衰减区百分比和间质性肺异常与重症COVID-19无显著关联。
核心结论
- 疫情前重度阻塞、限制性通气障碍及较高肺气肿百分比与重症COVID-19风险升高相关。
研究设计与样本
- 基于美国11个前瞻性一般人群队列,纳入29,323名参与者(平均年龄67岁),中位随访17.3个月(自2020年3月1日起)。
主要发现
- 随访期间共发生748例重症COVID-19。
- 重度阻塞(vs 正常)与重症COVID-19风险升高相关(aHR 2.11;95%CI 1.02-1.27)。
- 限制性通气障碍(vs 正常)与重症COVID-19风险升高相关(aHR 1.40;95%CI 1.12-1.76)。
- 肺气肿百分比最高四分位(vs 最低四分位)与重症COVID-19风险升高相关(aHR 1.64;95%CI 1.03-2.61)。
- 高衰减区百分比和间质性肺异常与重症COVID-19无显著关联。
关键数值与推荐
- 阻塞定义:FEV1/FVC < 0.70;限制定义:FEV1/FVC ≥ 0.7且FVC < 80%;重度阻塞:FEV1 < 50%。
临床怎么用
- 对肺功能受损个体应加强COVID-19风险缓解措施。
- COVID-19疫苗接种在重度阻塞、限制及肺气肿人群中提供更大的绝对风险降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Increased risk of coronavirus disease (COVID-19) hospitalization and death has been reported among patients with clinical lung disease. Objective: To test the association of objective measures of prepandemic lung function and structure with COVID-19 outcomes in U.S. adults. Methods: Prepandemic obstruction (FEV1/FVC < 0.70) and restriction (FEV1/FVC ⩾ 0.7, FVC < 80%) were defined based on the most recent spirometry exam conducted in 11 prospective U.S. general population-based cohorts. Severe obstruction was classified by FEV1 < 50%. Percentage emphysema, percentage high-attenuation areas, and interstitial lung abnormalities were defined on computed tomography in a subset. Incident COVID-19 was ascertained via questionnaires, serosurvey, and medical records from 2020 to 2023 and classified as severe (hospitalized or fatal) or nonsevere. Cause-specific hazard models were adjusted for sociodemographics, anthropometry, smoking, comorbidities, and COVID-19 vaccination status. Measurements and Main Results: Among 29,323 participants (mean age, 67 yr), there were 748 severe incident COVID-19 cases over median follow-up of 17.3 months from March 1, 2020. Greater hazards of severe COVID-19 were associated with severe obstruction (vs. normal; adjusted hazard ratio [aHR], 2.11; 95% confidence interval [CI], 1.02-1.27), restriction (vs. normal; aHR, 1.40; 95% CI, 1.12-1.76), and percentage emphysema (highest vs. lowest quartile; aHR, 1.64; 95% CI, 1.03-2.61), but not greater high-attenuation areas or interstitial lung abnormalities. COVID-19 vaccination provided greater absolute risk reduction in these groups. Results were similar in participants without smoking, obesity, or clinical cardiopulmonary disease. Conclusions: Prepandemic severe spirometric obstruction, spirometric restriction, and greater percentage emphysema lung on computed tomography were associated with risk of severe COVID-19. These findings support enhanced COVID-19 risk mitigation for individuals with impaired lung health and warrant further mechanistic studies on interactions of lung function, structure, and vulnerability to acute respiratory illnesses.
引用
- Balte PP, Kim JS, Sun Y, et al. Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study. Am J Respir Crit Care Med. 2025. PMID: 40238945. doi:10.1164/rccm.202408-1656OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。